Date: 2016-11-15
Type of information: Nomination
Compound:
Company: PharmaMar (Spain)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On November 15, 2016, PharmaMar announced that Pascal Besman has joined the company in the newly-created role of Chief Operating Officer, effective immediately. Mr. Besman will be based in New York and will oversee the implementation of PharmaMar’s operational infrastructure in the United States. Mr. Besman joins PharmaMar from Maxim Group, a New York-based global investment bank, where he served as Head of
Healthcare Equity Sales since 2014.
In addition to Maxim Group, Mr. Besman served as a healthcare specialist and institutional equity salesperson at several investment banks, including JMP Securities, UBS, Bear Stearns, Lehman Brothers and Merrill Lynch. He authored a widely-read weekly biotech overview newsletter for C-suite executives entitled The Buzz. Mr. Besman holds a B.Sc. from the London School of Economics.
Financial terms:
Latest news:
